Abstract
Since a vaccine is not available against Rhodococcus equi, R equi-specific hyperimmune plasma (HIP) is commonly used, although its efficacy remains controversial. The objective of this study was to evaluate the ability of a commercially available HIP to prevent clinical rhodococcal pneumonia in neonatal foals after experimental challenge.
Original language | English |
---|---|
Pages (from-to) | 261 |
Number of pages | 1 |
Journal | Veterinary Record |
Volume | 178 |
Issue number | 11 |
DOIs | |
State | Published - Mar 12 2016 |
ASJC Scopus subject areas
- Veterinary (all)